A carregar...
Effects of secukinumab on metabolic and liver parameters in plaque psoriasis patients
BACKGROUND: Psoriasis is associated with metabolic, liver and cardiovascular comorbidity. Secukinumab, a fully human monoclonal antibody that selectively neutralizes interleukin‐17A, has shown significant and sustained efficacy in the treatment of moderate to severe psoriasis. OBJECTIVES: This was a...
Na minha lista:
| Publicado no: | J Eur Acad Dermatol Venereol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7065121/ https://ncbi.nlm.nih.gov/pubmed/31599476 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdv.16004 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|